Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79.6M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
6.24M
-
Shares change
-
-8.83K
-
Total reported value, excl. options
-
$14.7M
-
Value change
-
-$15.1K
-
Put/Call ratio
-
0.24
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$2.36
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q1 2023
34 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2023.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.24M shares
of 79.6M outstanding shares and own 7.84% of the company stock.
Largest 10 shareholders include BVF INC/IL (2.33M shares), Cormorant Asset Management, LP (1.22M shares), VANGUARD GROUP INC (680K shares), Woodline Partners LP (517K shares), Ensign Peak Advisors, Inc (443K shares), CM Management, LLC (235K shares), Ikarian Capital, LLC (222K shares), GEODE CAPITAL MANAGEMENT, LLC (129K shares), JMAC ENTERPRISES LLC (54.5K shares), and BlackRock Inc. (52.6K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.